Locations:
SearchAdvertisement
The effect of mefloquine on acute leukemia cell lines
Brian Bolwell, MD, provides insights
Biomarker may help individualize treatment
Prospective review of parameters improves plan consistency, saves time
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Targeting pyrimidine synthesis inhibits GSC self-renewal and tumorigenesis
Positive outcomes reported for metastatic sarcomas
Study affirms XRT’s utility
Relapse more likely with faster PSA doubling time
Dose-escalation trial shows local control with low toxicity, low leptomeningeal recurrence
Involving a pediatric cardio-oncologist early in the treatment of pediatric malignancies
Advertisement
Advertisement